Founded in 2013, AbbVie Pharmaceuticals began as a part of the Chicago-based Abbott Laboratories. The global biopharmaceutical firm aims to address some of the world’s most important health challenges. It strives to discover, develop, and bring innovative science to solve these worldwide health issues. With more than 28,000 worldwide employees, AbbVie Pharmaceuticals markets its products to more than 170 countries.
In early October 2015, AbbVie Pharmaceuticals launched Voices of HS, which is a global campaign used to increase awareness about hidradenitis suppurativa (HS). HS is a painful, chronic inflammatory skin disease that affects about 1 percent of adults worldwide. Many people with HS live in isolation and face embarrassment. The campaign supports the HS community by offering education and increased awareness with physicians and patients. The firm launched the initiative at the 24th European Academy of Dermatology and Venereology Congress in Denmark.